Mohawk Industries (MHK) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
16 Apr, 2026Executive summary
Q4 2025 net sales reached $2.7 billion, up 2.4% as reported but down 3.3% on a constant basis year-over-year, with adjusted EPS at $2.00 and adjusted net earnings of $124 million.
Full-year 2025 sales were $10.8 billion, flat year-over-year; adjusted EPS was $8.96, down 7.5%, and adjusted net earnings were $559 million.
Free cash flow for 2025 was $621 million, with $150 million spent on share repurchases; Q4 free cash flow was ~$265 million.
Commercial segments outperformed residential, with strength in healthcare, education, and hospitality.
Housing turnover and consumer confidence remained weak due to affordability, inflation, and geopolitical tensions.
Financial highlights
Q4 2025 adjusted gross margin was 24.3%; adjusted operating margin was 5.6%; adjusted EBITDA was $301 million.
Q4 operating income was $68 million (2.5% margin) as reported; adjusted operating income was $152 million (5.6% margin).
Net debt at year-end 2025 was $1.17 billion; net debt to adjusted EBITDA improved to 0.9x.
Cash and cash equivalents at year-end were $856 million; inventories at $2.7 billion.
Net cash from operating activities for 2025 was $1.06 billion; capital expenditures were $435 million.
Outlook and guidance
Q1 2026 adjusted EPS expected between $1.75 and $1.85, with market conditions similar to Q4.
2026 sales and earnings anticipated to improve, driven by sales initiatives, product innovation, and operational improvements, but dependent on economic and housing market recovery.
Full-year 2026 tax rate forecasted at 18.5%-19.5%.
CapEx planned at $480 million for 2026, focused on innovation, cost reduction, and maintenance.
Recent restructuring initiatives expected to generate $60–70 million in savings in 2026.
Latest events from Mohawk Industries
- Annual meeting covers director elections, pay, new incentive plan, and key governance issues.MHK
Proxy filing3 Apr 2026 - Q2 adjusted EPS up 9% as cost actions and cash flow offset weak sales and market pressures.MHK
Q2 20242 Feb 2026 - Q3 2024 adjusted EPS up 7% to $2.90; 2025 recovery expected as rates decline.MHK
Q3 202418 Jan 2026 - Q1 2025 sales fell 5.7% to $2.53B; adjusted EPS $1.52; tariffs add $50M in costs.MHK
Q1 202525 Dec 2025 - Adjusted EPS steady at $1.95 as cost actions offset weak demand; $285M savings targeted.MHK
Q4 20249 Dec 2025 - Proxy covers director elections, auditor ratification, executive pay, and ESG priorities.MHK
Proxy Filing1 Dec 2025 - Q3 2025 sales up 1.4% to $2.8B, with $110M in savings and ongoing cost actions amid soft demand.MHK
Q3 202524 Oct 2025 - Flat Q2 2025 sales, margin pressure, and a $500M buyback amid ongoing cost and tariff risks.MHK
Q2 202525 Jul 2025